CB Insights
Technology Market Intelligence
Technology Market Intelligence
Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The Company's epigenetic drug discovery platfor...Show all
Company (Acquired)
Phone: 617-245-1300
70 Fargo Street
Suite 205
Boston, 02210
Massachusetts, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Acetylon Pharmaceuticals | $156.1M | Dec 2, 2016 |
| Xanthus Pharmaceuticals | $63.8M | Jun 9, 2008 |
| HNC Software | $0M | May 2, 2002 |
| See all 37 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Combinations of histone deacetylase inhibitors and immunomodulatory drugs | Dec 03, 2014 | Apr 24, 2018 | Patent |
| Pyrimidine hydroxy amide compounds as hdac6 selective inhibitors | Sep 09, 2016 | Feb 06, 2018 | Patent |
| Treatment of leukemia with histone deacetylase inhibitors | Jul 06, 2015 | Dec 05, 2017 | Patent |
| Piperidine derivatives as hdac1/2 inhibitors | Dec 11, 2015 | Oct 17, 2017 | Patent |
| Selective hdac1 and hdac2 inhibitors | Jul 19, 2016 | Sep 19, 2017 | Patent |
